Monopar Therapeutics Inc(DE:1IY0)
€63.80+0.60 (+9.25%)
DE:1IY0
Monopar Therapeutics Inc ownership
€63.80
At close:+0.60 (+9.25%)
Monopar Therapeutics Inc (1IY0) Ownership - Who Owns Monopar Therapeutics Inc?
0 Followers
Monopar Therapeutics Inc (1IY0) Ownership Overview
- 13.88% Insiders
- 5.79% Mutual Funds
- 2.02% Other Institutional Investors
- 9.19% ETFs
- 69.12% Public Companies and Individual Investors
The ownership structure of Monopar Therapeutics Inc (DE:1IY0) stock is a mix of institutional, retail, and individual investors. Approximately 17.00% of the company’s stock is owned by Institutional Investors, 13.88% is owned by Insiders, and 69.12% is owned by Public Companies and Individual Investors.
The ownership structure of Monopar Therapeutics Inc (DE:1IY0) stock is a mix of institutional, retail, and individual investors. Approximately 17.00% of the company’s stock is owned by Institutional Investors, 13.88% is owned by Insiders, and 69.12% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 03, 2026 | Raymond Anderson | $214,746 | |
| Dec 28, 2025 | Quan Anh Vu | $104,925 | |
| Dec 18, 2025 | Arthur Klausner | $343,889 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Driehaus Capital Management Llc | €2,201,589 | |
| Dec 31, 2025 | Deerfield Management Company, Lp | €11,137,437 | |
| Dec 31, 2025 | Ra Capital Management | €43,568,617 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Peter Kolchinsky | 667,207 | Institution | 9.94% | 47,235,587 |
| Diane Hendricks | 661,330 | Insider | 9.85% | 46,819,519 |
| BlackRock, Inc. | 348,819 | Institution | 5.20% | 24,694,990 |
| James E. Flynn | 323,745 | Institution | 4.82% | 22,919,851 |
| Vanguard | 244,176 | Institution | 3.64% | 17,286,684 |
| Vanguard Index Funds | 204,097 | Institution | 3.04% | 14,449,251 |
| Ishares | 183,694 | Institution | 2.74% | 13,004,800 |
| Chandler Robinson | 166,942 | Insider | 2.49% | 11,818,826 |
| Spdr | 159,197 | Institution | 2.37% | 11,270,511 |
| Steve Weber | 84,040 | Institution | 1.25% | 5,949,696 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 204,097 | Institution | 3.04% | 14,449,251 |
| Fidelity Salem Street Trust | 55,730 | Institution | 0.83% | 3,945,461 |
| Fidelity Concord Street Trust | 40,465 | Institution | 0.60% | 2,864,760 |
| Vanguard Scottsdale Funds | 30,589 | Institution | 0.46% | 2,165,579 |
| Bny Mellon Investment Funds I | 23,890 | Institution | 0.36% | 1,691,316 |
| Schwab Capital Trust | 13,953 | Institution | 0.21% | 987,817 |
| Tiaa-cref Funds | 5,980 | Institution | 0.09% | 423,360 |
| Vanguard Valley Forge Funds | 2,647 | Institution | 0.04% | 187,397 |
| Goldman Sachs Trust | 2,115 | Institution | 0.03% | 149,734 |
| Vanguard Institutional Index Funds | 2,105 | Institution | 0.03% | 149,026 |
FAQ
Who Owns Monopar Therapeutics Inc (DE:1IY0)?
According to the latest TipRanks data, approximately 17.00% of the company's stock is held by institutional investors, 13.88% is held by insiders, and 69.12% is held by public companies and individual investors.
What percentage of Monopar Therapeutics Inc (DE:1IY0) stock is held by institutional investors?
According to the latest TipRanks data, approximately 17.00% of Monopar Therapeutics Inc (DE:1IY0) stock is held by institutional investors: 5.79% by mutual funds, 9.19% by ETFs and 2.02% by other institutional investors.
What percentage of Monopar Therapeutics Inc (DE:1IY0) stock is held by retail investors?
According to the latest TipRanks data, approximately 69.12% of Monopar Therapeutics Inc (DE:1IY0) stock is held by public companies and individual investors.
Who owns the most shares of Monopar Therapeutics Inc (DE:1IY0)?
Peter Kolchinsky owns the most shares of Monopar Therapeutics Inc (DE:1IY0).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
